Encycle Therapeutics, a Toronto-based drug discovery company, announced a research collaboration with Pfizer to optimize certain nacellins.

This week, VBI Vaccines announced the closing of its public offering which raised approximately US$71.9 Million.

Profound Medical Corp. announced this week that treatments utilizing its TULSA-PRO® technology of Benign Prostatic Hyperplasia (“BPH”) are now being successfully conducted in Germany.

Tieös Pharmaceuticals, a next-generation biotech company focused on cancer metabolic therapies, was selected as a finalist in the 2017 BioInnovation Challenge being held in Halifax, Nova Scotia.

VivaVax is an early-stage life sciences company creating biosafe formulations to protect sensitive medicines from heat fluctuations during transport.

Last week they won the Vinetta Project Finals, which includes a cash prize of $15K, and $25K in legal support from Blakes.

Komodo OpenLabs (CAAP 2015) has won 1st Place at the highly competitive 2017 Interface Health Challenge with their TECLA line.

The prize has a total value of $40K and includes cash, services, and media. Their flagship TECLA product line helps those with physical disabilities effectively use modern day communications devices such as smartphones and tablets.

Mark Elias, Co founder and CEO was featured on CTV's MedicalWatch segment, demonstrating the company's battery-free Steadiglove technology.

Colin Harding, CEO of Iris Technologies authoured a blog featured on the BIST website. Iris Technologies has developed a unique e-reader solution helps people who have suffered from a mild traumatic brain injury (MTBI) or live with chronic migraines regain their ability to comfortably read electronic documents, and assist in their recovery process.

Deadline for Submission October 13, 2017, 5PM EST

Innovation Partnership: Procurement by Co-Design is a unique program that offers healthcare-service providers something rare: the opportunity to participate in the development of innovative solutions before procuring them. In turn, technology and service innovators with scalable business models can gain unprecedented access to end users and validate use cases to remain competitive.

The Ontario Minister of Health and Long-Term Care (the “Minister”) introduced Bill 160:
An Act to amend, repeal and enact various Acts in the interest of strengthening quality and
accountability for patients on September 27, 2017. One of the new enactments is the Health Sector Payment Transparency Act (the “Act”) which will require the reporting of information about financial relationships in the Ontario healthcare system.

TORONTO, ON (October 5, 2017) – Synaptive Medical, a leading Canadian medical device and technology company, announced today the appointment of veteran healthcare executive and current chairman of the board Peter Wehrly as chief executive officer. Cameron Piron will continue to serve as president and assume the new role of chief strategy officer.

Former MP for Kingston and the Islands Ted Hsu has been spending lots of time with his family since leaving politics behind in 2015, but now he is ready to take on a new challenge.

Hsu is the newest member of SYNG Pharmaceuticals, a Kingston-based company that is looking to help diagnose and treat endometriosis.

Ontario Genomics iannounced that Round 10 of their Genome Canada’s Genomic Applications Partnership Program is now open.

The Genomic Applications Partnership Program (GAPP) funds public-private research collaborations focused on developing genomics-derived technologies that address opportunities and challenges identified by industry, government, not-for-profits or other “Receptors” of genomics knowledge and tools.

EOI forms are due to Ontario Genomics on November 13th, 2017 at 9 am ET.

Information and Application

CAAP company SensOR Medical landed a cover page spot on Canadian Healthcare Technology's October 2nd issue, and highlighted their recent Dyson Award win.

Altair Ioffe of Ioffe Biotechnologies will be featured on the October 19th episode of Dragon's Den. Altair will be featuring their signature nootropic Indezone.

CAHO announced Michelle Noble as their new Executive Director effective November 1st, 2017.

The Centre for Aging & Brain Health Innovation (CABHI) has two funding programs that are accepting expressions of interest; Spark (Deadline October 11th!)  and I2P2 (Deadline October 16!).

The Canadian Space Agency (CSA), in partnership with the National Research Council of Canada's Industrial Research Assistance Program (IRAP), wishes to engage the biomedical, health and performance communities as well as space stakeholders to help identify potential Canadian health and biomedical roles in human deep space missions, and explore new ways to collaborate to improve the innovation process in both space and terrestrial health.

Ottawa, Ontario September 26, 2017 - Prime Minister, Justin Trudeau, today announced Dr. Mona Nemer as Canada’s new Chief Science Advisor, following an open, transparent, and merit-based selection process.

TORONTO, ONTARIO Sept. 26, 2017 - Interface Biologics, a privately held, commercial stage company developing innovative material science technologies that save lives and improve patient outcomes, is pleased to announce that Arkis BioSciences® has received 510(k) clearance from U.S. Food and Drug Administration (FDA) for its exclusive CerebroFlo™ EVD Catheter with IBI's Endexo® technology.